Emergent Biosolutions Inc. sell JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€1.86
Target price
20.11.24
-
Performance (%)
360.76%
End price
21.11.24
€8.58
Summary
This prediction ended on 21.11.24 with a price of €8.58. The price for Emergent Biosolutions Inc. massively increased, which is bad news for the SELL prediction by JPMorgan_Chase___Co_. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Emergent Biosolutions Inc. | -8.667% | -8.667% | 0.429% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Ratings data for EBS provided by MarketBeat
In the thread Trading Emergent Biosolutions Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten